Time-of-day differences in dopamine clearance in the rat medial prefrontal cortex and nucleus accumbens

Synapse

Volumn 62, Issue 12, 2008, Pages 877-885

  Sleipness, Evan P ^a   Jansen, Heiko T ^a   Schenk, James O ^a   Sorg, Barbara A ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

Circadian; Cocaine; Diurnal; Dopamine transporter; Reward

Indexed keywords

COCAINE; DOPAMINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CIRCADIAN RHYTHM; CLEARANCE; CONTROLLED STUDY; DARKNESS; ELECTRODE; INHIBITION KINETICS; LIGHT DARK CYCLE; MALE; NONHUMAN; NUCLEUS ACCUMBENS; POTENTIOMETRY; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT;

ACTIVITY CYCLES; ANIMALS; CIRCADIAN RHYTHM; COCAINE; DOPAMINE; MALE; METABOLIC CLEARANCE RATE; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; RATS; RATS, SPRAGUE-DAWLEY;

EID: 56549103655     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.20552     Document Type: Article

References (72)

1. Abarca C, Albrecht U, Spanagel R. 2002. Cocaine sensitization and reward are under the influence of circadian genes and rhythm. Proc Natl Acad Sci USA 99:9026-9030.
2. Abe M, Herzog ED, Yamazaki S, Straume M, Tei H, Sakaki Y, Menaker M, Block GD. 2002. Circadian rhythms in isolated brain regions. J Neurosci 22:350-356.
3. Akhisaroglu M, Ahmed R, Kurtuncu M, Manev H, Uz T. 2004. Diurnal rhythms in cocaine sensitization and in Period 1 levels are common across rodent species. Pharmacol Biochem Behav 79:37-42.
4. Anderson SM, Schmidt HD, Pierce RC. 2006. Administration of the D2 dopamine receptor antagonist sulpiride into the shell, but not the core, of the nucleus accumbens attenuates cocaine priming-induced reinstatement of drug seeking. Neuropsychopharmacology 31:1452-1461.
5. Bauer MS. 1992. Irradiance responsivity and unequivocal type-1 phase responsivity of rat circadian activity rhythms. Am J Physiol 263(5, Part 2):R1110-R1114.
6. Becker JB, Beer ME, Robinson TE. 1984. Striatal dopamine release stimulated by amphetamine or potassium: Influence of ovarian hormones and the light-dark cycle. Brain Res 311:157-160.
7. Cagampang FR, Rattray M, Campbell IC, Powell JF, Coen CW. 1998. Variation in the expression of the mRNA for protein kinase C isoforms in the rat suprachiasmatic nuclei, caudate putamen and cerebral cortex. Brain Res Mol Brain Res 53:277-284.
8. Castaneda TR, de Prado BM, Prieto D, Mora F. 2004. Circadian rhythms of dopamine, glutamate and GABA in the striatum and nucleus accumbens of the awake rat: Modulation by light. J Pineal Res 36:177-185.
9. Chevillard C, Barden N, Saavedra JM. 1981. Twenty-four hour rhythm in monoamine oxidase activity in specific areas of the rat brain stem. Brain Res 223:205-209.
10. Daniels GM, Amara SG. 1999. Regulated trafficking of the human dopamine transporter. Clathrin-mediated internalization and lysosomal degradation in response to phorbol esters. J Biol Chem 274:35794-35801.
11. DeLucia R, Planeta CS, Ferreira MP, Aizenstein ML, Scavone C. 1997. Circadian time-dependent effects of fencamfamine on inhibition of dopamine uptake and release in rat striatal slices. Braz J Med Biol Res 30:637-640.
12. Deroche V, Marinelli M, Le Moal M, Piazza PV. 1997. Glucocorticoids and behavioral effects of psychostimulants. II. Cocaine intravenous self-administration and reinstatement depend on glucocorticoid levels. J Pharmacol Exp Ther 281:1401-1407.
13. Devoto P, Flore G, Saba P, Fa M, Gessa GL. 2005. Co-release of noradrenaline and dopamine in the cerebral cortex elicited by single train and repeated train stimulation of the locus coeruleus. BMC Neurosci 6:31.
14. Dietz DM, Tapocik J, Gaval-Cruz M, Kabbaj M. 2005. Dopamine transporter, but not tyrosine hydroxylase, may be implicated in determining individual differences in behavioral sensitization to amphetamine. Physiol Behav 86:347-355.
15. Dunlap JC, Loros JJ, DeCoursey PJ, editors. 2004. Chronobiology: Biological timekeeping. Sunderland, MA: Sinauer Associates. 406 p.
16. Eshleman AJ, Henningsen RA, Neve KA, Janowsky A. 1994. Release of dopamine via the human transporter. Mol Pharmacol 45:312-316.
17. Feenstra MG, Botterblom MH, Mastenbroek S. 2000. Dopamine and noradrenaline efflux in the prefrontal cortex in the light and dark period: Effects of novelty and handling and comparison to the nucleus accumbens. Neuroscience 100:741-748.
18. Fox HC, Hong KA, Paliwal P, Morgan PT, Sinha R. 2008. Altered levels of sex and stress steroid hormones assessed daily over a 28-day cycle in early abstinent cocaine-dependent females. Psychopharmacology (Berl) 195:527-536.
19. Gabriel R, Lesauter J, Silver R, Garcia-Espana A, Witkovsky P. 2001. Diurnal and circadian variation of protein kinase C immunoreactivity in the rat retina. J Comp Neurol 439:140-150.
20. Garris PA, Collins LB, Jones SR, Wightman RM. 1993. Evoked extracellular dopamine in vivo in the medial prefrontal cortex. J Neurochem 61:637-647.
21. Giros B, Caron MG. 1993. Molecular characterization of the dopamine transporter. Trends Pharmacol Sci 14:43-49.
22. Goeders NE, Guerin GF. 1996. Role of corticosterone in intravenous cocaine self-administration in rats. Neuroendocrinology 64:337-348.
23. Gu H, Wall SC, Rudnick G. 1994. Stable expression of biogenic amine transporters reveals differences in inhibitor sensitivity, kinetics, and ion dependence. J Biol Chem 269:7124-7130.
24. Harms E, Kivimae S, Young MW, Saez L. 2004. Posttranscriptional and posttranslational regulation of clock genes. J Biol Rhythms 19:361-373.
25. Hastings MH, Herzog ED. 2004. Clock genes, oscillators, and cellular networks in the suprachiasmatic nuclei. J Biol Rhythms 19:400-413.
26. Jansen K, Van der Zee EA, Gerkema MP. 2003. Not only vasopressin, but also the intracellular messenger protein kinase Calpha in the suprachiasmatic nucleus correlates with expression of circadian rhythmicity in voles. Neuropeptides 37:57-65.
27. Kalivas PW, Volkow ND. 2005. The neural basis of addiction: A pathology of motivation and choice. Am J Psychiatry 162:1403-1413.
28. Kamase H. 1980. The diurnal variations of monoamine oxidase activity in discrete nuclei of rat brain. Folia Psychiatr Neurol Jpn 34:481-492.
29. Kawarai T, Kawakami H, Yamamura Y, Nakamura S. 1997. Structure and organization of the gene encoding human dopamine transporter. Gene 195:11-18.
30. Liu T, Borjigin J. 2005. Free-running rhythms of pineal circadian output. J Biol Rhythms 20:430-440.
31. Loder MK, Melikian HE. 2003. The dopamine transporter constitutively internalizes and recycles in a protein kinase C-regulated manner in stably transfected PC12 cell lines. J Biol Chem 278:22168-22174.
32. Mantsch JR, Schlussman SD, Ho A, Kreek MJ. 2000. Effects of cocaine self-administration on plasma corticosterone and prolactin in rats. J Pharmacol Exp Ther 294:239-247.
33. McClung CA, Sidiropoulou K, Vitaterna M, Takahashi JS, White FJ, Cooper DC, Nestler EJ. 2005. Regulation of dopaminergic transmission and cocaine reward by the Clock gene. Proc Natl Acad Sci USA 102:9377-9381.
34. McElvain JS, Schenk JO. 1992. A multisubstrate mechanism of striatal dopamine uptake and its inhibition by cocaine. Biochem Pharmacol 43:2189-2199.
35. McFarland K, Kalivas PW. 2001. The circuitry mediating cocaine-induced reinstatement of drug-seeking behavior. J Neurosci 21:8655-8663.
36. Moore RY. 1983. Organization and function of a central nervous system circadian oscillator: The suprachiasmatic hypothalamic nucleus. Fed Proc 42:2783-2789.
37. Moore RY, Eichler VB. 1972. Loss of a circadian adrenal corticosterone rhythm following suprachiasmatic lesions in the rat. Brain Res 42:201-206.
38. Moron JA, Brockington A, Wise RA, Rocha BA, Hope BT. 2002. Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter: Evidence from knock-out mouse lines. J Neurosci 22:389-395.
39. Mundorf ML, Joseph JD, Austin CM, Caron MG, Wightman RM. 2001. Catecholamine release and uptake in the mouse prefrontal cortex. J Neurochem 79:130-142.
40. Negus SS, Mello NK, Portoghese PS, Lukas SE, Mendelson JH. 1995. Role of delta opioid receptors in the reinforcing and discriminative stimulus effects of cocaine in rhesus monkeys. J Pharmacol Exp Ther 273:1245-1256.
41. Park WK, Bari AA, Jey AR, Anderson SM, Spealman RD, Rowlett JK, Pierce RC. 2002. Cocaine administered into the medial prefrontal cortex reinstates cocaine-seeking behavior by increasing AMPA receptor-mediated glutamate transmission in the nucleus accumbens. J Neurosci 22:2916-2925.
42. Paulson PE, Robinson TE. 1994. Relationship between circadian changes in spontaneous motor activity and dorsal versus ventral striatal dopamine neurotransmission assessed with on-line microdialysis. Behav Neurosci 108:624-635.
43. Paulson PE, Robinson TE. 1996. Regional differences in the effects of amphetamine withdrawal on dopamine dynamics in the striatum. Analysis of circadian patterns using automated on-line microdialysis. Neuropsychopharmacology 14:325-337.
44. Perreau-Lenz S, Kalsbeek A, Garidou ML, Wortel J, van der Vliet J, van Heijningen C, Simonneaux V, Pevet P, Buijs RM. 2003. Suprachiasmatic control of melatonin synthesis in rats: Inhibitory and stimulatory mechanisms. Eur J Neurosci 17:221-228.
45. Rea MA. 1998. Photic entrainment of circadian rhythms in rodents. Chronobiol Int 15:395-423.
46. Refinetti R. 2006. Circadian physiology. New York: CRC Press. 667 p.
47. Reiter RJ. 1991. Melatonin: The chemical expression of darkness. Mol Cell Endocrinol 79:C153-C158.
48. Reppert SM, Weaver DR. 2001. Molecular analysis of mammalian circadian rhythms. Annu Rev Physiol 63:647-676.
49. Reppert SM, Weaver DR. 2002. Coordination of circadian timing in mammals. Nature 418:935-941.
50. Ritz MC, Lamb RJ, Goldberg SR, Kuhar MJ. 1987. Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science 237:1219-1223.
51. Rivera-Bermudez MA, Gerdin MJ, Earnest DJ, Dubocovich ML. 2003. Regulation of basal rhythmicity in protein kinase C activity by melatonin in immortalized rat suprachiasmatic nucleus cells. Neurosci Lett 346:37-40.
52. Sanchez CJ, Bailie TM, Wu WR, Li N, Sorg BA. 2003. Manipulation of dopamine D1-like receptor activation in the rat medial prefrontal cortex alters stress- and cocaine-induced reinstatement of conditioned place preference behavior. Neuroscience 119:497-505.
53. Sarnyai Z, McKittrick CR, McEwen BS, Kreek MJ. 1998. Selective regulation of dopamine transporter binding in the shell of the nucleus accumbens by adrenalectomy and corticosterone-replacement. Synapse 30:334-337.
54. Schade R, Vick K, Ott T, Sohr R, Pfister C, Bellach J, Golor G, Lemmer B. 1995. Circadian rhythms of dopamine and cholecystokinin in nucleus accumbens and striatum of rats-influence on dopaminergic stimulation. Chronobiol Int 12:87-99.
55. Schenk JO. 2002. The functioning neuronal transporter for dopamine: Kinetic mechanisms and effects of amphetamines, cocaine and methylphenidate. Prog Drug Res 59:111-131.
56. Schwartz WJ, de la Iglesia HO, Zlomanczuk P, Illnerova H. 2001. Encoding le quattro stagioni within the mammalian brain: Photoperiodic orchestration through the suprachiasmatic nucleus. J Biol Rhythms 16:302-311.
57. Segall LA, Perrin JS, Walker CD, Stewart J, Amir S. 2006. Glucocorticoid rhythms control the rhythm of expression of the clock protein. Period 2, in oval nucleus of the bed nucleus of the stria terminalis and central nucleus of the amygdala in rats. Neuroscience 140:753-757.
58. Shalev U, Marinelli M, Baumann MH, Piazza PV, Shaham Y. 2003. The role of corticosterone in food deprivation-induced reinstatement of cocaine seeking in the rat. Psychopharmacology (Berl) 168:170-176.
59. Shim HS, Kim H, Lee J, Son GH, Cho S, Oh TH, Kang SH, Seen DS, Lee KH, Kim K. 2007. Rapid activation of CLOCK by Ca2+-dependent protein kinase C mediates resetting of the mammalian circadian clock. EMBO Rep 8:366-371.
60. Silvia CP, Jaber M, King GR, Ellinwood EH, Caron MG. 1997. Cocaine and amphetamine elicit differential effects in rats with a unilateral injection of dopamine transporter antisense oligodeoxynucleotides. Neuroscience 76:737-747.
61. Sinha R, Garcia M, Paliwal P, Kreek MJ, Rounsaville BJ. 2006. Stress-induced cocaine craving and hypothalamic-pituitary-adrenal responses are predictive of cocaine relapse outcomes. Arch Gen Psychiatry 63:324-331.
62. Sleipness EP, Sorg BA, Jansen HT. 2005. Time of day alters long-term sensitization to cocaine in rats. Brain Res 1065:132-137.
63. Sleipness EP, Sorg BA, Jansen HT. 2007a. Contribution of the suprachiasmatic nucleus to day:night variation in cocaine-seeking behavior. Physiol Behav 91:523-530.
64. Sleipness EP, Sorg BA, Jansen HT. 2007b. Diurnal differences in dopamine transporter and tyrosine hydroxylase levels in rat brain: Dependence on the suprachiasmatic nucleus. Brain Res 1129:34-42.
65. Sulzer D, Chen TK, Lau YY, Kristensen H, Rayport S, Ewing A. 1995. Amphetamine redistributes dopamine from synaptic vesicles to the cytosol and promotes reverse transport. J Neurosci 15(5, Part 2):4102-4108.
66. Sumova A, Bendova Z, Sladek M, Kovacikova Z, Illnerova H. 2004. Seasonal molecular timekeeping within the rat circadian clock. Physiol Res 53 (Suppl 1):S167-S176.
67. Sun W, Rebec GV. 2005. The role of prefrontal cortex D1-like and D2-like receptors in cocaine-seeking behavior in rats. Psychopharmacology (Berl) 177:315-323.
68. Tyler-McMahon BM, Stewart JA, Jackson J, Bitner MD, Fauq A, McCormick DJ, Richelson E. 2001. Altering behavioral responses and dopamine transporter protein with antisense peptide nucleic acids. Biochem Pharmacol 62:929-932.
69. Uz T, Akhisaroglu M, Ahmed R, Manev H. 2003. The pineal gland is critical for circadian Period1 expression in the striatum and for circadian cocaine sensitization in mice. Neuropsychopharmacology 28:2117-2123.
70. Wayment HK, Schenk JO, Sorg BA. 2001. Characterization of extracellular dopamine clearance in the medial prefrontal cortex: Role of monoamine uptake and monoamine oxidase inhibition. J Neurosci 21:35-44.
71. Wirz-Justice A. 1974. Possible circadian and seasonal rhythmicity in an in vitro model: Monoamine uptake in rat brain slices. Experientia 30:1240-1241.
72. Yuferov V, Butelman ER, Kreek MJ. 2005. Biological clock: Biological clocks may modulate drug addiction. Eur J Hum Genet 13:1101-1103.